Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
22.62
-0.48 (-2.08%)
At close: Sep 11, 2026, 4:00 PM EDT
22.81
+0.19 (0.84%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.51 billion as of September 11, 2026. Its market cap has increased by 131.88% in one year.
Market Cap
1.51B
Enterprise Value
1.01B
1-Year Change
131.88%
Ranking
Category
Stock Price
$22.62
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.51B, an increase of 62.01%. That is a compound annual growth rate of 27.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.51B | 63.71% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.61B |
| AnaptysBio | 1.60B |
| Novavax | 1.55B |
| Avalyn Pharma | 1.49B |
| Innoviva | 1.48B |
| Ascentage Pharma Group International | 1.47B |
| Latigo Biotherapeutics | 1.47B |
| LB Pharmaceuticals | 1.44B |